Mesa Labs Declares Quarterly Dividend | Your money
Lakewood, Colorado, Oct. 01, 2021 (GLOBE NEWSWIRE) – Mesa Laboratories, Inc. (NASDAQ: MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its board of administration has declared a regular quarterly dividend of $ 0.16 per common share. The dividend will be payable on December 15, 2021 to shareholders of record at the close of business on November 30, 2021.
About Mesa Laboratories, Inc.
Mesa is a global leader in the design and manufacture of critical quality control solutions for the pharmaceutical, healthcare and medical device industries. Mesa offers products and services through four divisions (sterilization and disinfection control, biopharmaceutical development, instruments and continuous monitoring) to help our customers ensure product integrity, increase patient and worker safety and to improve the quality of life around the world.
This press release may contain information that constitutes forward-looking statements. Forward-looking statements are subject to risks and uncertainties which could cause actual results to differ materially from our historical experience and current expectations or projections. Forward-looking statements include statements relating to revenues and growth, results of operations, pressure on profit margins, industry conditions, economic conditions, demand, competition, the effects of additional steps taken to become more efficient or reduce costs, risks associated with business integration, changes in legal and regulatory issues, the ability to generate additional cash flow, and the duration and impact of the COVID-19 pandemic and the myriad of its effects on our business, including associated declines in customer demand and spending, and any events or developments that we expect or anticipate will occur in the future. In general, the words “expect”, “seek”, “anticipate”, “intend to”, “plan”, “believe”, “can”, “estimate”, “can”, “target” , “Project” and similar expressions identify forward-looking statements. However, the absence of such words or similar expressions does not mean that a statement is not forward-looking. These statements are based on current information and expectations. Actual results may differ materially from those estimated or anticipated due to these risks and unknowns or other risks and uncertainties. For more information regarding these and other risks and uncertainties that could affect these statements and our business, see our Annual Report on Form 10-K for the year ended March 31, 2021, as well as other risks and uncertainties. detailed from time to time. times in our reports on Forms 10-Q and 8-K subsequently filed with the Securities and Exchange Commission. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. We do not undertake to republish forward-looking statements revised to reflect events or circumstances after the date hereof, to provide updates, or to reflect the occurrence of future events.
For more information about the Company, please visit its website at www.mesalabs.com
MEDIA CONTACT: Gary Owens; President and CEO, or John Sakys; Chief Financial Officer, both of Mesa Laboratories, Inc., + 1-303-987-8000
Copyright 2021 GlobeNewswire, Inc.